Science | Nature | Cell | View More
Bioactive Products
Vasorelaxation Compound Library
A unique collection of 38 Vasorelaxation natural compound library for Vasorelaxation screening
Catalog No: Bb1221 Vasorelaxation Compound Library
Screening Details
Size: 1mg/well * 38 Compounds
2mg/well * 38 Compounds
Cat. No. Information
CFN92022 Przewaquinone A

Przewaquinone A has antitumor activity.
CFN92060 Syringaresinol

(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1α through activation of FOXO3 is a potential therapeutic strategy for ischemia-related diseases. Syringaresinol induces vasorelaxation by enhancing NO production in endothelial cells via two distinct mechanisms, phosphatidylinositol 3-kinase/Akt- and PLC/Ca(2+)/CaMKKβ-dependent eNOS phosphorylation and Ca(2+)-dependent eNOS dimerization.
CFN92343 Leachianone G

Leachianone G exhibits significant antioxidant potentials in the ABTS, ONOO(-), and total ROS assays, it also shows inhibitory activities against pancreatic lipase, it may be used as drug candidate to control obesity. Leachianone G shows potent antiviral activity (IC(50) = 1.6 microg/ml). (+/-)Leachianone G 1b, bearing 8-prenyl and 2',4'-dihydoxyl groups, exhibits potent vasorelaxant and neuroprotective effects.
CFN92432 8-Hydroxypinoresinol

8-Hydroxypinoresinol has antioxidant activity,it and phillygenin significantly reduce the cell injury by 3-morpholinosydnonimine (SIN-1), a ONOO− generator, may be useful for the therapeutic or preventive applications in treating ONOO−-related diseases.
CFN92553 Isorhyncophylline

Isorhyncophylline and rhyncophylline can directly inhibit the contractile responses induced by several agonists in small blood vessels of rat, they also can inhibit the hypertensive effect of angiotensin Ⅱ.